Prevalence of Murray Valley encephalitis virus antibodies in northern Victoria following the 2023 outbreak: a cross-sectional serological survey
Communicable Diseases Intelligence · 2025
DOI: 10.33321/cdi.2025.49.020 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Communicable Diseases Intelligence, 2025. Verfasst von Marie Heloury und 16 weiteren Autor:innen. Beteiligte Einrichtung: Communicable Diseases Section, Victorian Department of Health, Melbourne, 3000, Australia. Hauptthemen laut MEDLINE: Antibodies, Viral, Encephalitis Virus, Murray Valley, Disease Outbreaks, Encephalitis, Arbovirus. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Following the first outbreak of Murray Valley encephalitis in Victoria, Australia, since 1974, a serological survey was conducted in 2023 and 2024 to estimate the seroprevalence of Murray Valley encephalitis virus (MVEV) antibodies among residents in the north of the state. Between October 2023 and April 2024, a total of 507 residents from 11 local government areas in northern Victoria — Mildura, Swan Hill, Campaspe, Gannawarra, Greater Bendigo, Loddon, Greater Shepparton, Moira, Wodonga, Wangaratta, and Indigo — were tested for MVEV total antibody. Seroprevalence was 2.0% (95% confidence interval: 1.1–3.6%), comparable to background levels of seropositivity prior to the 2023 outbreak. No strong associations were identified between a range of potential risk or protective factors and MVEV seropositivity. Low seroprevalence suggests that the population in this region remains immunologically vulnerable to MVEV infection. Ongoing vector control and efforts to prevent mosquito bites will be critical in preventing flavivirus transmission in northern Victoria during future mosquito seasons.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Communicable Diseases Section, Victorian Department of Health, Melbourne, 3000, Australia.
- Victorian Infectious Diseases Reference Laboratory, Melbourne Health, The Peter Doherty Institute for Infection and Immunity, Melbourne, 3000, Australia.
- Australian National University, Canberra, 2600, Australia.
- Department of Infectious Diseases, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, 3000, Australia.
- Loddon Mallee Public Health Unit, Bendigo Health, Bendigo, 3550, Australia.
- Violet Vines Centre for Rural Health Research, La Trobe Rural Health School, La Trobe University, P.O. Box 199, Bendigo, VIC, 3552, Australia.
Zitieren
APA
Heloury, M., Szanyi, J., Braddick, M., Fidao, A., Marsland, M. J., Thomson, T. N., Batty, M., Nicholson, S., Karapanagiotidis, T., Carville, K. S., Glynn-Robinson, A. J., Lim, C. K., Tenneti, N., Zheng, A., Cross, W., Black, J., & O'Brien, H. (2025). Prevalence of Murray Valley encephalitis virus antibodies in northern Victoria following the 2023 outbreak: a cross-sectional serological survey. Communicable Diseases Intelligence. https://doi.org/10.33321/cdi.2025.49.020
Vancouver
Heloury M, Szanyi J, Braddick M, Fidao A, Marsland MJ, Thomson TN, et al. Prevalence of Murray Valley encephalitis virus antibodies in northern Victoria following the 2023 outbreak: a cross-sectional serological survey. Communicable Diseases Intelligence. 2025. doi:10.33321/cdi.2025.49.020
BibTeX
@article{Heloury2025,
author = {Heloury, Marie and Szanyi, Joshua and Braddick, Maxwell and Fidao, Alexander and Marsland, Madeleine J and Thomson, Tilda N and Batty, Mitch and Nicholson, Suellen and Karapanagiotidis, Theo and Carville, Kylie S and Glynn-Robinson, Anna-Jane and Lim, Chuan Kok and Tenneti, Naveen and Zheng, Anthony and Cross, William and Black, Jim and O'Brien, Helen},
title = {Prevalence of Murray Valley encephalitis virus antibodies in northern Victoria following the 2023 outbreak: a cross-sectional serological survey},
journal = {Communicable Diseases Intelligence},
year = {2025},
doi = {10.33321/cdi.2025.49.020}
}
EUVIMED